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Abstract
The aim of this study was to examine the hypoglycemic effect of chlorella in 6 week-old type 2 diabetic Goto-Kakizaki (GK, n=30) rats and
6 week-old normal Wistar (n=30) rats. Animals were randomly assigned to 3 groups respectively, and were fed three different experimental diets
containing 0%, 3% or 5% (w/w) chlorella for 8 weeks. In diabetic GK rats, the insulinogenic-indices were not significantly different among the
groups. The concentrations of fasting plasma glucagon and hepatic triglyceride, and the insulin/glucagon ratios of the GK-3% chlorella and GK-5%
chlorella groups were significantly lower than those of the GK-control group. The HOMA-index and the concentrations of fasting blood glucose
and plasma insulin of the GK-3% chlorella and GK-5% chlorella groups were slightly lower than those of the GK-control group. In normal Wistar
rats, the insulinogenic-indices were not significantly different among the normal groups, but that of the Wistar-5% chlorella group was slightly 
higher than the other groups. The concentrations of fasting blood glucose and plasma insulin, and the HOMA-index of the Wistar-5% chlorella 
group were a little higher, and the fasting plasma glucagon concentration and the insulin/glucagon ratio of the Wistar-5% chlorella group were
significantly higher than those of the Wistar-control and Wistar-3% chlorella groups. In conclusion, this study shows that the glucose-stimulated
insulin secretion was not affected by the intake of chlorella, which could be beneficial, however, in improving insulin sensitivity in type 2 diabetic
GK and normal Wistar rats. 
Key Words: Chlorella, glucagon, Goto-kakizaki rat, insulin, insulin sensitivity 
Introduction4)
Diabetes mellitus, both insulin-dependent (type 1 diabetes) and 
non-insulin-dependent (type 2 diabetes), is a common and serious 
disorder throughout the world (Harris et al., 1987; Keen, 1986). 
The number of people with diabetes is increasing all over the 
world because of population growth, aging, urbanization, and 
increasing prevalence of obesity and physical inactivity (Wild 
et al., 2004). The dietary habit has become westernized, and the 
intake of processed food has increased because the rate of 
economic growth has increased rapidly and the standard of living 
has improved in Korea. Moreover, the intake of micronutrients, 
vitamins and minerals, has reduced (Chen et al., 1991; Kim & 
Paek, 1997). With these changes of dietary life, the mortality 
of diseases such as cancer, heart disease, hypertension and 
diabetes has risen steadily these days. The incidence of diabetes 
over 30 years old has increased from 6.6% in 1998 to 8.1% 
in 2005 (Ministry of Health and Welfare, 1999; Ministry of 
Health and Welfare, 2006), and many diabetic experts are 
predicting that the incidence of diabetes would increase steadily 
(Rhee, 2003). Most of the Koreans have type 2, non-insulin 
dependent diabetes mellitus (Song et al., 2007). 
Type 2 diabetes is one of the chronic metabolic disorders. 
Reduction of insulin secretion and impairment of insulin action 
cause an abnormal metabolic regulation. Type 2 diabetes is made 
up of multiple forms, each of which is characterized by variable 
degrees of insulin resistance and β-cell dysfunction, which 
together leads to hyperglycemia (Bernard, 2005). Insulin 
resistance is associated with a number of metabolic disorders. 
If hyperglycemic status is kept for a long time, it can cause 
cardiovascular diseases such as hyperlipidemia and hypertension. 
(Haffner et al., 1998). Moreover, insulin resistance is a common 
physiologic abnormality characterized by an impaired response 
to insulin in insulin sensitive tissues such as muscle, liver, and 
adipose tissues, and it is a major symptom of type 2 diabetes 
(Simonson & Kendalla, 2005). Hence many people have made 
efforts to improve insulin resistance. Dietary effort is one of the 
helpful solutions in improving insulin resistance. A lot of studies 
have evaluated effects of natural products safety confirmed to 
improve and prevent diseases. Representatively, chlorella is 
worthy of notice.
Chlorella has long been a popular functional food in Asian 
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Table 1. General composition of Chlorella Vulgaris powder
Components Content (g)
Protein 60.600
Carbohydrate  3.700
Fat 12.800
Dietary Fiber 13.000
Ash 4.500
Moisture 5.400
Chlorophyll 2.400
Carotene 0.106
Vitamin C 0.074
Vitamin E  0.023
Total 100.000
Calorie (kcal) 372.000
Table 2. Composition of experimental diets (Unit: g/kg diet)
Groups
1)
Ingredient
GK-Control GK-3% chlorella GK-5% chlorella
Wistar-Control Wistar-3% 
chlorella
Wistar-5% 
chlorella
Cornstarch 397.486 385.561 377.612
Dextrinized Cornstarch 132.000 128.040 125.400
Sucrose 100.000 97.000 95.000
Casein 200.000 194.000 190.000
Soybean oil 70.000 67.900 66.500
Cellulose 50.000 48.500 47.500
Mineral mixture (G)
2) 35.000 33.950 33.250
Vitamin mixture
3) 10.000 9.700 9.500
L-cystine 3.000 2.910 2.850
Choline bitartrate 2.500 2.425 2.375
Tert-butylhydroquinone 0.014 0.014 0.013
Chlorella powder 0.000 30.000 50.000
Total 1,000.000 1,000.000 1,000.000
Energy content (kcal) 3736.21 3735.75 3735.40
1)  GK-Control:  GK  rat+AIN-93  diet
GK-3%chlorella:  GK  rat+3%  chlorella  diet  (w/w)
GK-5%chlorella:  GK  rat+5%  chlorella  diet  (w/w)
Wistar-Control:  Wistar  rat+AIN-93  diet 
Wistar-3%chlorella:  Wistar  rat+3%  chlorella  diet  (w/w)
Wistar  -5%chlorella  :  Wistar  rat+5%  chlorella  diet  (w/w)
2) M i n e r a l  m i x  ( A I N - 9 3 G - M I X )  ( g / k g  m ix t u r e ) :  a n h y d r o u s  c a l c i u m  c arbonate  357, 
monobasic  potassium  phosphate  196,  sodium  chloride  74,  potassium  sulfate 
46.6, tripotassium citrate monohydrate 70.78, magnesium oxide 24, ferric citrate 
6.06,zinc  carbonate  1.65,  manganous  carbonate  0.63,  cupric  carbonate  0.3, 
potassium  iodate  0.01,  anhydrous  sodium  selenate  0.01025, 
ammoniumparamolybdate  4-hydrate  0.00795,  sodium  metasilicate  9-hydrate 
1.45, chromium potassium sulfate 12-hydrate 0.275, boric acid 0.0815, sodium 
fluoride  0.0635,  nickel  carbonate  0.0318,  lithium  chloride  0.0174,  ammonium 
vanadate  0.0066,  powered  sucrose  221.026 
3)  Vitamin  mix  (AIN-93-VX)  (g/kg  mixture):  nicotinic  acid  3,  Ca-pantothenate  1.6, 
pyridoxine-HCl 0.7, thiamin-HCl 0.6, riboflavin 0.6, folic acid 0.2, D biotin 0.02, 
vitamin B12 (0.1% cyanocobalamin in mannitol) 2.5, vitamin E (all-rac-α-tocopheryl 
acetate,  500  IU/g)  15,  vitamin  A  (all-trans-retinyl  palmitate,  500,000  IU/g)  0.8, 
vitamin D3  (cholecalciferol, 400,000 IU/g) 0.25, vitamin K (phylloquinone) 0.075, 
powdered  sucrose  974.655
countries including Korea, Japan and Taiwan. It has little 
bio-availabilities and is acknowledged as good food (Cherng & 
Shih, 2005a). Chlorella is a good source of protein, lipid soluble 
vitamins, choline, dietary fiber and essential minerals. Many 
studies have been performed to figure out the biochemical and 
physiological functions of chlorella, such as promoting the 
growth rate of animals, boosting immune function, preventing 
stress-induced ulcers, and preventing high-fat diet induced 
dyslipidemia. The effects of chlorella, such as fatigue recovery, 
degradation of toxic materials, heavy metal removal, and 
environmental application were also studied (Cherng & Shih, 
2005a; Cherng & Shih, 2005b; Han et al., 2002; Kang et al., 
2004; Sano et al., 1988). The hypoglycemic effect is one of them. 
Although the acute administration of chlorella produced a 
significant hypoglycemic effect in alloxan-induced rats or 
streptozotocin (STZ)-induced mice (Cherng & Shih, 2005a; 
Rodiriguez-Lopez, 1964), it is difficult to explain that long-term 
intake of chlorella has hypoglycemic effect. Also, previous 
studies used the type 1 diabetic model that suggested that 
chlorella doesn’t affect insulin secretion but improves insulin 
resistance. This could not explain the hypoglycemic effect of 
chlorella in type 2 diabetes. Therefore, it is necessary to study 
about the effects of the long-term chlorella intake on type 2 
diabetic model. Thus, this study examined if the intake of 
chlorella had a hypoglycemic effect in six week-old GK rats with 
type 2 diabetes and normal Wistar rats, respectively.
Materials and Methods
Preparation of Chlorella 
Chlorella used in this experiment was supplied by Daesang 
Co. Ltd., (Korea) in powdered form of Chlorella Vulgaris. The 
specification of chlorella is shown in Table 1.
Animals
Thirty six week-old male GK rats [GK/Slc, inbred, Tohoku 
University School of Medicine Origin; Jung-Ang Lab Aminal, 
Inc., Korea] and thirty six week-old male Wistar rats [Slc 
:Wistar/ST, outbred, Institute of Medical Science Origin; 
Jung-Ang Lab Animal, Inc., Korea] were placed in individual 
stainless steel wire-mesh cages in a climate-controlled room. The 
room had a 12 hour light-dark cycle, a temperature of 22-24℃, 
and a relative humidity of 45 ± 5%. This study was conducted 
at the nutrition laboratory of Ewha Womans University, in 
compliance with the Guide for the Care and Use of Laboratory 
Animals (Nutrition Research Council, 1995). The rats were fed 
a pellet diet (Samyang Co., Korea) for the first seven days 
(adaptation period). The GK rats weighed 139.30 ± 12.86 g and 
the Wistar rats weighed 175.40 ± 5.75 g after the adaptation 
period. The body weight of GK rat is 10-30% lower than that 
of the age and sex-matched Wistar rat (Bernard, 2005). They 
were then stratified according to body weight and randomly 
blocked into three groups for the experimental periods, which 
lasted for eight weeks, respectively. 
Experimental dietsHyejin Jeong et al. 25
The compositions of experimental diets are shown in Table 
2. The experimental diets were formulated according to the 
nutrient content of the 93G diet of the American Institute of 
Nutrition (AIN) (Reeves et al., 1993), with slight modification. 
Three different experimental diets replaced the control diet, with 
different levels of chlorella (0%, 3% or 5%, w/w). There were 
no differences in total calories among the three experimental 
diets. Cornstarch (Daesang Co., Korea), sucrose (Dyets, Inc., 
USA), Dextrinized cornstarch (Dyets, Inc., USA), were used as 
sources of carbohydrate. Soybean oil (CJ Co., Korea) was used 
as a source of lipid. Casein (Murray Goulburn Co-operative Co., 
Australia) was used as a source of protein. Mineral and vitamin 
mixtures were prepared in accordance with the 1993 recom-
mendation of the AIN (Dyets, Inc., USA). All the other materials 
were purchased from Dyets Inc. (USA). 
The rats were allowed free access to the experimental diets 
and deionized water during the experimental period. Body weight 
was recorded once a week. To determine the food intake, the 
amount of food offered was weighed and the weight of scraps 
and waste were recorded three times per week.
Specimen collection 
At the end of the experimental period, the animals were fasted 
for 12 hours. The rats were sacrificed after anesthetization with 
ethyl ether. The liver samples were frozen in liquid nitrogen and 
stored at -80℃ until analysis for indices of lipid levels. The blood 
samples were collected directly from the heart, using syringes 
treated with either heparin (5,000 IU/mL) or 3.8% sodium citrate. 
Blood samples collected with heparinized syringes were 
transferred to polypropylene tubes, and those treated with 3.8% 
sodium citrate were transferred to polypropylene tubes containing 
ethylenediaminetetraacetic acid (EDTA) and polypropylene tubes 
containing 500 IKU/mL of aprotinin (Sigma-Aldrich Co., USA), 
which were placed in an ice bath for 20 minutes and the blood 
samples contained in polypropylene tubes were centrifuged at 
2,800 rpm for 30 minutes at 4℃ (Union 55R centrifuge, Hanil, 
Korea). The aprotinin is an inhibitor of proteolytic enzymes 
including chymotrypsin, plasmin, trypsin, elastase, kallikrein, et 
cetra. Treatment of EDTA and aprotinin to the blood samples 
is recommended to avoid breakdown of glucagons (Wakasugi, 
1989). Then plasma was transferred to microtubes. Heparin- 
treated plasma was frozen at -80℃  until analysis for insulin 
concentration. Plasma treated with EDTA was frozen at -80℃ 
until analysis for activities of AST and ALT, and concentrations 
of total protein and albumin. Plasma treated with EDTA and 
aprotinin was frozen at -80℃ until analysis for concentration 
of glucagons (Wakasugi, 1989).
Measurements 
Measurement of liver function and toxicity: The total lipid 
concentration of liver was measured using the method of Bligh 
& Dyer (Bligh & Dyer, 1959). The lipid extract from the liver 
was dissolved in 5 mL methanol, and concentrations of triglyceride 
and total cholesterol were determined using a kit (Asan 
Pharmaceutical, Korea) based on an enzymatic colorimetric 
method, respectively (Fossati & Prencipe, 1982; McGowan et 
al., 1983). Plasma aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) activities were measured using a kit 
(Asan Pharmaceutical, Korea) based on the Reitman-Frankel 
method (Reitman & Frankel, 1957). Plasma total protein 
concentration was measured using a kit (Asan Pharmaceutical, 
Korea) based on Biuret reaction (Layne, 1957). Plasma albumin 
concentration was measured using a kit (Asan Pharmaceutical, 
Korea) based on Bromocresol green (BCG) method (Webster et 
al., 1974). 
Plasma metabolite and hormone measurements: Blood glucose 
concentrations were determined immediately with an Accu-check 
(Roche diagnostics, Germany) at 0 and 30 minutes after glucose 
administration. Collected blood samples that were transferred to 
microtubes containing heparin were placed in an ice bath for 
20 minutes and centrifuged at 4,000 rpm for 7 minutes at 4℃. 
Then enzyme-linked immunosorbent assay (ELISA) kit (Mercodia, 
Sweden) was used to determine the concentration of plasma 
insulin. Enzyme immunoassay (EIA) kit (Yanaihara Institute Inc., 
Japan) was used to determine the concentration of plasma 
glucagon concentration. 
HOMA-IR:  The fasting blood glucose and plasma insulin 
concentrations were used to calculate the homeostasis model 
assessment-insulin resistance (HOMA-IR): [HOMA-IR=(fasting 
plasma insulin (μg/L)×fasting blood glucose (mg/dL)/22.5)] 
(Asano  et al., 2007; Nunes et al., 2007).
Insulinogenic-index:  At six weeks after the feeding of 
experimental diets, all rats were fasted for 12 hours before the 
glucose-stimulated insulin secretion test. Glucose (1 g/kg body 
weight) was administrated orally, and blood samples were 
collected with heparinized capillary tubes from the ophthalmic 
vein at 0 and 30 minutes for measurement of blood glucose and 
plasma insulin concentrations. Then, insulinogenic-index was 
calculated using equation: [Insulinogenic-index = (30 min plasma 
insulin-fasting plasma insulin) / (30 min blood glucose-fasting 
blood glucose)] (Asano et al., 2007; Jue et al., 2003; Pratley 
& Weyer, 2002). 
Statistical analysis
All experiments were performed in duplicate and all statistical 
analyses were performed by the SAS program package version 
9.1. All results were expressed as the mean ± standard error (SE). 
The data were analyzed by one-way analysis of variance 
(ANOVA) and differences between experimental groups were 
evaluated using Duncan’s multiple range tests at the P < 0.05 
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Table 3. Daily food intake, calorie intake, body weight gain, food efficiency ratio in rats fed experimental diets
Groups
1) Food intake
(g/day)
Calorie intake
(kcal/day)
Body weight gain
(g/ 8 weeks) 
Food efficiency ratio
2) 
(g/ 100 kcal)
GK-Control 19.68 ± 1.38
3),NS4) 73.51 ± 5.14
NS 177.86 ± 12.86
NS 4.35 ± 0.54
NS
GK-3% chlorella 19.39 ± 0.94 72.45 ± 3.52 182.23 ± 15.37 4.51 ± 0.45
GK-5% chlorella 19.53 ± 1.18 72.95 ± 4.39 181.57 ± 15.95 4.47 ± 0.52
Wistar-Control 23.37 ± 1.23
NS 86.94 ± 4.58
NS 241.72 ± 9.83
NS 4.98 ± 0.24
NS
Wistar-3% chlorella 23.15 ± 1.79 86.47 ± 6.71 254.25 ± 42.58 5.20 ± 0.50 
Wistar-5% chlorella 22.13 ± 1.01 82.68 ± 3.77 234.80 ± 25.84 5.00 ± 0.44
1)  See  Table  2.
2)  Food  efficiency  ratio  (g/100  kcal)  = Body  weight  gain  (g)  /  100  calorie  intake  (kcal)
3)  Mean ± standard  error  (n=10)
4)  Values  are  not  significantly  different  among  the  groups  at  α=0.05  using  Duncan’s  multiple  range  test.
Table 4. Plasma AST and ALT activities in rats fed experimental diets
(Unit: IU/L)
Groups
1) AST ALT Total protein Albumin
GK-Control 35.25 ± 2.74
2),NS3) 11.70 ± 1.95
NS 7.03 ± 0.31
NS 3.48 ± 0.44
NS
GK-3% 
chlorella
38.56 ± 4.35 11.67 ± 2.50 6.86 ± 0.11 3.76 ± 0.24
GK-5% 
chlorella
37.49 ± 7.69 10.07 ± 2.35 6.87 ± 0.39 3.50 ± 0.17
Wistar-Control 45.18 ± 8.05
NS 14.93 ± 4.31
NS 6.93 ± 0.30
NS 3.71 ± 0.41
NS
Wistar-3% 
chlorella
45.52 ± 7.42 13.60 ± 1.79 6.50 ± 0.64 3.67 ± 0.40
Wistar-5% 
chlorella
41.39 ± 7.27 14.28 ± 2.50 6.64 ± 0.20 3.49 ± 0.23
1)  See  Table  2.
2)  Mean ± standard  error  (n=10)
3) Values are not significantly different among the groups at α=0.05 using Duncan’s 
multiple  range  test.
Table 5. Liver concentrations of total lipids, triglyceride, and total cholesterol
in rats fed experimental diets  (Unit : mg/g wet liver)
Groups
1) Total lipids Triglyceride Total cholesterol
GK-Control 15.68 ± 3.85
2),NS3)  3.91 ± 1.44
a4) 0.85 ± 0.15
NS
GK-3% chlorella 10.82 ± 5.03  2.25 ± 1.18
b 0.54 ± 0.39
GK-5% chlorella 10.93 ± 4.97  2.51 ± 1.37
b 0.64 ± 0.52
Wistar-Control 29.35 ± 16.07
NS 11.17 ± 3.07
NS 0.85 ± 0.33
NS
Wistar-3% chlorella 29.38 ± 10.09 11.73 ± 2.42 0.94 ± 0.35
Wistar-5% chlorella 23.03 ± 10.07 11.54 ± 4.36 0.83 ± 0.52
1)  See  Table  2.
2)  Mean ± standard  error  (n=10)
3) Values are not significantly different among the groups at α=0.05 using Duncan’s 
multiple  range  test.
4)  Values  with  different  letters  within  the  cell  are  significantly different  at α=0.05 
using  Duncan’s  multiple  range  test.
Table 6. Insulinogenic-index in rats fed experimental diets for 6 weeks 
Groups
1) Insulinogenic-index
2)
GK-Control 0.0012 ± 0.0007
3),NS4)
GK-3% chlorella 0.0011 ± 0.0010
GK-5% chlorella 0.0015 ± 0.0007
Wistar-Control 0.0030 ± 0.0019
NS
Wistar-3% chlorella 0.0031 ± 0.0021
Wistar-5% chlorella 0.0052 ± 0.0059
1)  See  Table  2.
2)  Insulinogenic  index=glucose  concentration  difference  (mg/dL)  /  insulin 
concentration  difference  (μg/L) 
3)  Mean ± standard  error  (n=10)
4) Values are not significantly different among the groups at α=0.05 using Duncan’s 
multiple  range  test.
Results
Food intake and body weight gain 
Food intake, calorie intake, body weight gain and food efficacy 
are shown in Table 3. In both diabetic GK and normal Wistar 
rats, there were no significant differences among the groups.
Liver function and toxicity 
In Table 5, the hepatic triglyceride concentrations of the 
GK-3% chlorella and GK-5% chlorella groups were significantly 
lower than that of the GK-control group. The liver concentrations 
of total lipid and total cholesterol were not significantly affected 
by the intake of chlorella. In normal Wistar rats, the 
concentrations of total lipid, triglyceride and total cholesterol 
were not influenced by the intake of chlorella.
The plasma AST and ALT activities are shown in Table 4. 
There were no significant differences among the diabetic GK 
groups. In normal Wistar rats, the activities were within the 
reference range of 39.92-92 IU/L for AST activity and 17-50 
IU/L for ALT activity (The Koreas Society of Food Science and 
Nutrition, 2000). Therefore, the intake of chlorella with different 
levels did not affect liver and heart function and was regarded 
as nontoxic in diabetic GK and normal Wistar rats. 
As shown in Table 4, the plasma total protein and albumin 
concentrations were not significantly different among the diabetic 
groups, and the concentrations were within the reference ranges 
of 6.3-8.6 g/dL for plasma total protein concentration and 3.3-4.9 
g/dL for plasma albumin concentration in normal Wistar rats (The 
Koreas Society of Food Science and Nutrition, 2000). As the 
result, feeding of chlorella did not cause protein malnutrition in 
diabetic GK and normal Wistar rats.
Insulinogenic-index
As shown in Table 6, there was no significant difference of 
the insulinogenic-indices in both diabetic GK and normal Wistar 
rats, but that of the 5% chlorella fed group was slightly higher 
than those of the control and 3% chlorella groups in normal 
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Table 7. Fasting blood glucose, plasma insulin and glucagon concentrations, HOMA-IR, and insulin/glucagon ratio in rats fed experimental diets
Groups
1) Blood glucose
(mg/dL)
Plasma insulin
(μg/L)
Plasma glucagon
(pg/mL) HOMA-IR
2) Insulin/glucagon ratio
GK-Control 274.63 ± 44.47
3),NS4) 1.36 ± 0.42
NS 614.50 ± 190.70
a5) 16.83 ± 6.32
NS 2.60 ± 0.85
b
GK-3% chlorella 248.56 ± 73.07 1.21 ± 0.23 319.90 ± 82.87
b 13.67 ± 5.55 4.12 ± 0.78
a
GK-5% chlorella 251.00 ± 37.28 1.17 ± 0.33 342.28 ± 120.15
b 13.42 ± 5.41 3.88 ± 0.95
a
Wistar-Control 141.75 ± 23.27
NS 1.35 ± 0.45
NS 239.29 ± 46.22
b  8.28 ± 2.46
NS 5.43 ± 1.04
a
Wistar-3% chlorella 138.57 ± 14.62 1.19 ± 0.58 252.99 ± 42.70
b  7.51 ± 3.94 4.98 ± 0.74
a
Wistar-5% chlorella 136.43 ± 15.29 0.83 ± 0.48 328.81 ± 93.85
a  4.99 ± 3.00 2.81 ± 0.61
b
1)  See  Table  2.
2)  HOMA-IR  =  Fasting  glucose  concentration  (mg/dL) × Fasting  insulin  concentration  (μg/L)  /  22.5
3)  Mean ± standard  error  (n=10)
4)  Values  are  not  significantly  different  among  the  groups  at  α=0.05  using  Duncan’s  multiple  range  test.
5)  Values  with  different  letters  within  the  cell  are  significantly  different  at  α=0.05  using  Duncan’s  multiple  range  test.
HOMA-index and Concentrations of fasting blood glucose, 
plasma insulin and glucagon
Table 7 showed the HOMA-index and concentrations of fasting 
blood glucose, plasma insulin and glucagon. In diabetic GK rats, 
there were no significant difference of the HOMA-IR and the 
concentrations of the fasting blood glucose and plasma insulin. 
However, the fasting plasma glucagon concentrations and 
insulin/glucagon ratios of the GK-3% chlorella and GK-5% 
chlorella groups were significantly lower than those of the 
GK-control group. In normal Wistar rats, the HOMA-IR and the 
concentrations of the fasting blood glucose and plasma insulin 
were not significantly decreased by the intake of the experimental 
diet containing 5% chlorella, but the fasting plasma glucagon 
concentration and insulin/glucagon ratio of the Wistar-5% 
chlorella group were significantly higher than those of the 
Wistar-control and the Wistar-3% chlorella groups.
Discussion
The aim of this study was to examine the hypoglycemic effect 
of chlorella in type 2 diabetic Goto-Kakizaki (GK) and normal 
Wistar rats. During the experimental period, the insulinogenic- 
index was calculated to determine the effect of chlorella on the 
insulin secretion capacity. At the end of the experiment, the 
concentrations of the fasting blood glucose, plasma insulin, 
glucagon and hepatic lipids were measured, and the homeostatic 
model assessment-insulin resistance (HOMA-IR) was calculated 
using the fasting blood glucose and plasma insulin concentrations 
to examine the effect of chlorella intake on the insulin sensitivity.
First of all, the insulinogenic-index was calculated using the 
blood glucose and the plasma insulin concentration changes 
during the 30 minutes after the administration of glucose as a 
marker of the insulin secretion at six weeks after the feeding 
of experimental diets that contained different levels of chlorella. 
Goto-Kakizaki rats are resistant to the action of insulin and the 
compensatory attempt by the β-cells to release more insulin is 
not sufficient to maintain blood glucose concentrations, leading 
to the functional exhaustion of the surviving β-cells (Bernard, 
2005). It was expected that the intake of chlorella could improve 
the glucose-stimulated insulin secretion, but it was observed that 
the insulinogenic-indices of the diabetic GK rats were not 
influenced by the intake of chlorella. Moreover, those of the 
normal Wistar rats were not significantly different among the 
group either, but that of the Wistar-5%chlorella groups was very 
slightly higher than those of the Wistar-control, Wistar-3% 
chlorella groups. Previous studies (Cherng & Shih, 2005b; 
Rodríguez-López & López-Quijada, 1971) reported that chlorella 
had no influence on insulin secretion. 
In the work using alloxan induced-diabetic Wistar, type 1 
diabetic model, rats were injected intraperitoneally of chlorella 
pyrenoidosa (1 mg/kg body weight). Forty-eight hours later, the 
plasma glucose and insulin concentrations were measured in the 
rats fasted for 15 hours. The plasma glucose concentrations of 
the alloxan induced-diabetic Wistar rats fell clearly when 
chlorella was injected, but the plasma insulin concentration was 
unchanged. The study concluded that the injection of chlorella 
did not affect the fasting plasma insulin concentration in type 
1 diabetic rats (Rodríguez-López & López-Quijada, 1971). 
Another study also evaluated the effect on insulin secretion of 
chlorella in streptozotocin (STZ)-induced diabetic mice (type 1 
diabetic model). Twenty minutes before the blood collection, 100 
mg/kg of chlorella or H2O was administrated to the STZ mice 
and normal mice. The insulin concentrations of the chlorella 
treated STZ mice and normal mice were not different from the 
H2O-treated STZ mice and normal mice (Cherng & Shih, 2005b). 
These results of previous studies are somewhat in accordance 
with the results of this study that the intake of chlorella affects 
the insulin secretion capacity very slightly or not at all in both 
GK and Wistar rats. Chlorella might have the plasma glucose 
lowering effect, but that is not the effect of chlorella on insulin 
secretion. 
Some biomarkers were measured to evaluate whether chlorella 
has hypoglycemic effects via enhancement of insulin sensitivity 
or not. To examine the effects of chlorella to improve the insulin 
sensitivity, the concentrations of the fasting blood glucose, 
plasma insulin, glucagon and hepatic lipids were measured, and 
the HOMA-IR was calculated in diabetic GK and normal Wistar 
rats, respectively.28 Hypoglycemic effect of chlorella
The fasting blood glucose concentrations of the chlorella fed 
groups were tended to be lower than those of the chlorella 
non-fed group in diabetic GK rats. That seems to be leading 
to the small reduction of the plasma insulin concentrations. The 
high glucose and insulin concentrations are leading to 
hyperinsulinemia in type 2 diabetes. However, there was no 
significant difference of the fasting insulin concentrations 
between the chlorella non-fed groups despite of diabetes. It is 
assumed that the GK rats used in this study were six-week old. 
The insulin resistance of the young diabetic animals might be 
less than that of old diabetic animals and thus the insulin 
concentration might be not significantly different. 
Consistent with the slightly lower fasting blood glucose 
concentrations of chlorella fed groups, the HOMA-IR of chlorella 
fed groups was tended to be lower. The HOMA-IR calculated 
using the fasting blood glucose and plasma insulin concentration 
is a method used to quantify insulin resistance and β-cell function 
(Asano  et al., 2007; Matthews et al., 1985). Since the lower 
HOMA-IR means that the fasting blood glucose and/or insulin 
concentration is low, insulin resistance could be slightly reduced 
by the intake of chlorella in diabetic GK rats. 
The slightly lower HOMA-IR of the chlorella fed groups seems 
to be related with the significantly lower hepatic triglyceride (TG) 
concentrations. Insulin resistance is related to dyslipidemia. 
Excessive glucose can be stored as glycogen in the liver and 
muscles or as TG by the lipogenesis pathway in adipose tissues 
(Cherng & Shin, 2006; Smith et al., 2005). When insulin 
resistance induces the lipolysis of adipose tissues, plasma 
non-esterified free fatty acids (NEFA) are also increased, thus 
affecting the liver. The excessive plasma NEFA is stored as TG 
in the liver and used for gluconeogenesis to induce hyperglycemia 
(Boden  et al., 1998), and that could inhibit insulin-stimulated 
glucose utilization in muscles (Roden et al., 1996). In contrast, 
the reduction of plasma NEFA concentration could improve 
glucose utilization (Reaven et al., 1988) and enhance the 
suppression of hepatic glucose production by insulin (Saloranta 
et al., 1991), and reduce the high insulin concentration in type 
2 diabetes (Boden et al., 1998). 
Although the plasma NEFA concentration was not measured 
in this study, the work of Cherng and Shin (Cherng & Shin, 
2006) measured that in STZ-induced diabetic mice after acute 
chlorella treatment (100 mg/kg of chlorella). The serum NEFA 
concentration of the chlorella administrated STZ-induced diabetic 
mice was significantly lower than that of the H2O administrated 
STZ-induced diabetic mice. Moreover, glucose uptake in the 
livers and muscles was increased after chlorella administration 
in STZ-induced diabetic and normal mice. The lowered NEFA 
concentration and enhanced glucose uptake in STZ-induced 
diabetic mice by the administration of chlorella could support 
the significantly lower hepatic TG concentrations in type 2 
diabetic GK rats by the intake of chlorella. Therefore, these 
results from the chlorella fed groups could suggest the 
improvement of insulin resistance by the intake of chlorella in 
diabetic GK rats.
The plasma glucagon concentrations of the chlorella fed groups 
were significantly lower than that of the chlorella non-fed group. 
The significantly lower plasma glucagon concentrations of the 
chlorella fed groups were connected to the significantly higher 
insulin/glucagon ratio in diabetic GK rats. These significant 
effects could support the possibility of chlorella to help the 
improvement of hyperglucagonemia in type 2 diabetes. Because 
type 2 diabetes is a chronic metabolic disorder that not only is 
resulted from insulin resistance, but also is characterized by 
relative glucagons excess and pancreatic α-cell dysfunction. The 
characteristics of hyperglucagonemia are decreased sensitivity of 
cells to insulin or glucose and disturbances of insulin secretion 
(Ferrannini, 2007; Unger, 1978). A study of Choi et al. (2004) 
suggested that the duration of diabetes and poor glycemic control 
might be closely associated with relative hyperglucagonemia in 
Korean type 2 diabetic patients. Moreover, it has been reported 
that the absolute concentration of glucagon or the ratio of insulin 
to glucagon are often lowered in diabetes in both animals and 
human subjects (Jiang & Zhang, 2003; Unger, 1978). 
The effect of chlorella on fasting glucagon concentration is 
similar to excendin-4 isolated from the venom of the Gila monster 
Heloderma suspectum. Glucagon-like peptide-1 is an incretin, 
which is intestinal hormone that enhances glucose-induced insulin 
secretion after meals. Glucagon-like peptide-1 is metabolized 
extremely rapidly in the circulation by the enzyme dipeptidyl 
peptidase-IV (DPP-IV), but excendin-4, a glucagon-like peptide-1 
(GLP-1) receptor agonist, is resistant to the DPP-IV. Exenatide, 
synthetic exendin-4, has recently received FDA approval in the 
US for the treatment of type 2 diabetes (Briones & Bajaj, 2006; 
Park, 2007) and improves glycemic control in patients with 
diabetes through acute mechanisms, such as glucose-dependent 
stimulation of insulin secretion, suppression of inappropriate 
glucagon secretion and slowing of gastric emptying, as well as 
chronic mechanisms that include enhancement of ß-cell mass in 
rodent studies, and weight loss and inhibition of food intake in 
humans (Egan et al., 2002; Kolterman et al., 2002; Mahler & 
Adler, 1999). Although the incensement of insulin secretion, the 
effect of exenatide, was not shown by the intake of chlorella, 
exenatide and chlorella intake show similar effect of lowering 
glucagon concentration. This could support that the intake of 
chlorella is beneficial to improvement of type 2 diabetes by 
decreasing glucagon concentration. 
Taken together, the intake of chlorella significantly reduced 
the insulin/glucagon ratio, the concentrations of fasting plasma 
glucagon and hepatic TG. Also, the concentrations of fasting 
blood glucose and plasma insulin, the level of HOMA-IR were 
slightly decreased by the intake of chlorella. Considering the 
results described above, the intake of chlorella might improve 
insulin resistance and enhance insulin sensitivity in type 2 
diabetic GK rats. 
The hypoglycemic effects of chlorella intake were also 
evaluated in normal Wistar rats. The fasting blood glucose and Hyejin Jeong et al. 29
plasma insulin concentrations of chlorella fed groups were tended 
to be lower than those of the chlorella non-fed group. Especially, 
the plasma insulin concentrations were slightly lowered in 
accordance with chlorella doses. The HOMA-IR was also 
decreased by chlorella intake in a dose-dependent manner. However, 
the plasma glucagon concentration of the 5% chlorella fed group 
was significantly higher than those of the other groups, and the 
insulin/glucagon ratio was significantly lower compared to other 
groups. 
Insulin and glucagon are the key regulatory hormones for 
glucose homeostasis. The absolute concentrations and, even more 
so, the ratios of these two hormones are tightly regulated 
depending on nutritional status (Fanelli et al., 2006; Smith et al., 
2005). Chlorella is expected to promote the action of counter- 
regulatory hormones to rise in circulating glucose concentration, 
such as catecholamine, glucagon and adrenocorticotropic hormone 
in the fasting state. This is supported by the results that increased 
glucagon concentration of the 5% chlorella fed Wistar group to 
maintain blood glucose concentration in normal state, glycemic 
homeostasis. Because the glucagon concentration of the 5% 
chlorella fed group was significantly higher and the insulin/ 
glucagon ratio was significantly lower among the normal groups, 
yet the blood glucose concentrations were not different in 
accordance with the intake of chlorella, it might be assumed that 
small amount of insulin was used efficiently by the intake of 
chlorella. In consistence with this assumption, the HOMA-IR was 
lower in chlorella fed groups. 
In consequences, the intake of the 5% chlorella significantly 
increased the fasting glucagon concentration and insulin/ 
glucagon ratio in normal Wistar rats. Also, the concentrations 
of fasting blood glucose and plasma insulin, the levels of the 
HOMA-IR of the 5% chlorella fed group were a little decreased. 
According to the above results, this study could suggest that the 
intake of chlorella could be beneficial to the improvement of 
insulin sensitivity in normal Wistar rats.
Considering the results of this study in type 2 diabetic GK 
and normal Wistar rats, these alterations by chlorella might 
perhaps be related to the potential hypoglycemic effects. However, 
it is difficult to make sure that chlorella has a hypoglycemic 
effect certainly because the results of this study were unclear. 
Moreover, there are only few studies performed to support the 
hypoglycemic effect of chlorella. Therefore, further studies are 
required to evaluate the effect with higher doses of chlorella to 
ensure that chlorella has hypoglycemic effects and to find that 
effective doses of chlorella are responsible for the positive effect 
on insulin sensitivity. In addition, some biomarkers, such as the 
plasma NEFA level and glucose uptake rate into the cell are 
also needed to examine the mechanism on how chlorella acts 
as a hypoglycemic agent. Finally, chlorella could be available 
as an anti-diabetic functional food when further studies identify 
the hypoglycemic effects of chlorella.
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